Assessment of inflammatory bowel disease by using two different 99mTc leucocyte labelling methods

Nuclear Medicine Communications

Volumn 23, Issue 8, 2002, Pages 715-720

  Cardoso, V N ^a   Plaza, P J L ^a   Roca, M ^b   Armero, F ^b   Martyn Comin J ^b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

99mTc white blood cell labelling; Hank's balanced salt solution; Inflammatory bowel disease

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; DIAGNOSTIC AGENT; HANKS BALANCED SALT SOLUTION; ISOTONIC SOLUTION; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CELL LABELING; CELL SUSPENSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; GASTROINTESTINAL TRACT SCINTISCANNING; HUMAN; IMAGE ANALYSIS; INCUBATION TIME; ISOTOPE LABELING; MAJOR CLINICAL STUDY; MALE; RELIABILITY; RETROSPECTIVE STUDY; ULCERATIVE COLITIS; ADOLESCENT; CELL FREE SYSTEM; COMPARATIVE STUDY; ENTERITIS; LABORATORY DIAGNOSIS; LEUKOCYTE; LEUKOCYTE COUNT; METHODOLOGY; MIDDLE AGED; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CELL-FREE SYSTEM; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; ISOTONIC SOLUTIONS; ISOTOPE LABELING; LEUKOCYTE COUNT; LEUKOCYTES; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M EXAMETAZIME;

EID: 0035991745     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200208000-00003     Document Type: Article

References (17)

1. 99mTc-HMPAO-leukocytes for imaging infection. Semin Nucl Med 1994; 24: 110-127.
2. Datz FL. Indium-111-labelled leukocytes for the detection of infection: current status. Semin Nucl Med 1994; 24: 92-109.
3. Datz FL, Thorne DA. Effect of chronicity of infection on the sensitivity of the In-111-labelled leukocyte scan. Am J Roentgenol 1986; 147: 809-812.
4. 99mTc-labelled interleukin-8. J Nucl Med 2001; 42: 117-123.
5. 99mTc-HMPAO labelled leukocytes in inflammatory bowel disease. Eur J Nucl Med 1995; 22: 664-670.
6. Becker W, Goldenberg DM, Wolf F. The use of monoclonal antibodies and antibody fragments in the imaging of infectious lesions. Semin Nucl Med 1994; 24: 142-153.
7. 99mTc Infecton imaging with radiolabelled white-cell imaging in the evaluation of bacterial infection. Lancet 1996; 347: 233-235.
8. Huub JJM, Rennen OC, Boerman WJG, Wim JGO, Corstens FHM. Imaging infection/inflammation in the new millenium. Eur J Nucl Med 2001; 28: 241-252.
9. McAfee JG, Thakur ML. Survey of radioactive agents for in vitro labelling of phagocytic leukocytes. J Nucl Med 1976; 17: 480-487.
10. Martin-Comin J, Prats E. Clinical applications of radiolabelled blood elements in inflammatory bowel disease. Q J Nucl Med 1999; 43: 74-82.
11. 111In-tropolonate autologus granulocyte scintigraphy in the assessment of inflammatory bowel disease. Scand J Gastroenterol 1990; 178: 93-98.
12. 99mTc-hexamethylpropylene amine oxime for labelling leukocytes and imaging inflammation. Lancet 1986; 25: 946-949.
13. Roca M, Martin-Comin J, Becker W, et al. A consensus protocol for white blood cells labelling with technetium-99m hexamethylpropyleneamine oxime. Eur J Nucl Med 1998; 25: 797-799.
14. Almers S, Granerus G, Franzén M. Technetium-99m scintigraphy: more accurate assessement of ulcerative colitis with exametazine-labelled leukocytes than with antigranulocyte antibodies. Eur J Nucl Med 1996; 23: 247-255.
15. Becker W, Fischbach W, Weppler M, Mosl B, Jacoby G, Börner W. Radiolabelled granulocytes in inflammatory bowel disease: Diagnostic possibilities and clinical indications. Nucl Med Commum 1988; 9: 693-701.
16. 111In tagged leukocytes in the diagnosis of inflammatory bowel disease. Lancet 1981; 2: 230-237.
17. 111In-labelled autologous leukocytes in inflammatory bowel disease. Gastroenterology 1981; 80: 1273.